Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

5-HT4 receptor agonists and bladder disorders

Article Abstract:

Ferguson and Christopher proposed self-catheterization as a treatment of urinary bladder disorders. Although acceptable, this method is unpleasant and may cause irritation of the urethra and internal sphincter. To remedy the problem, patients with bladder disfunction may be treated by activation of neuronal serotonin/5-HT4 receptors in detrusor muscle. Evidence show that these receptors potentiate cholinergic neuromuscular transmission in the destrusor to increase bladder voiding efficiency.

Author: Tonini, M., Candura, S.M.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1996
Care and treatment, Usage, Parasympathomimetic agents, Bladder diseases

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Rational design of peptide agonists of cell-surface receptors

Article Abstract:

A novel approach to the design of peptide agonists of cell-surface receptors is discussed. Topics include interaction of the major histocompatibility complex class I molecule Dk-(61-85) with the insulin receptor, modification of Dk-(61-85) for biological specificity, and development of an activator of the erythropoietin receptor.

Author: Taylor, Simeon I.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 2000
Peptides, Major histocompatibility complex, Peptide regulatory factors, Erythropoietin, Peptide synthesis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoning

Article Abstract:

Researchers are working on drugs that would inhibit the A1 adenosine receptor in order to prevent organophosphate poisoning. These drugs would also inhibit other excitatory receptors, which would prevent convulsions and damage to the nervous system.

Author: Helden, Herman P.M. van, Bueters, Tjerk J.H.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1999
Health aspects, Prevention, Organophosphorus compounds, Organic phosphorus compounds, Adenosine, Poisoning

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research
Similar abstracts:
  • Abstracts: The 5-HT(sub 4) receptor: a place in the sun. The 5-HT(sub 7) receptor: orphan found. Of mice and flies: commonalities among 5-HT receptors
  • Abstracts: Neurotrophins and depression. Gamma-hydroxybutyric acid: an endogenous neuromodulator with abuse potential? Regulation of brain neurotrophin expression by physiological activity
  • Abstracts: Multiple P2 receptor subtypes on platelets: a new interpretation of their function. Endogenous ligands and inverse agonism
  • Abstracts: Festschrift in honour of Professor Sir Colin Dollery. TiPS on identity. Careers in media: life one step away from research
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.